Replies to post #10561 on Anavex Life Sciences Corp (AVXL)

[Doktornolittle]

Holy Mother of Pearl!

[mixedup]

If everything holds up and Anavex has the blockbuster that we all hope it has, it will need a partnership. Dr. Missling has stated this in at least two interviews. Anavex would not receive all income. The drug would dominate the market, but the revenue shared. PPS could be in the hundreds, but not a thousand plus. That's crazy. Hell, even talking like this is crazy. One step at a time.

AVXL

[InforichIH]

Dr. Missling cited a UBS study of the AD "market as big as $13 billion to $67 billion" in his presentation to the OneMed Forum 8 on January 13. The Webcast link is on the company website; see slide 7. That's a big range.

Also the Alzheimer's market is estimated to be worth $20 billion, according to Margaret Patrick reporting on "The Market's Response to Biogen's and Eli Lilly's Alzheimer's Drugs" at the Alzheimer's Association International Conference on July 22. (article in news releases of July 28).

AVXL valuation is also affected to some extent by the full range of indications in the rich pipeline, shown on the Co. website. Enough for now to note that future development and trials will require more funds, so the 162 million outstanding shares will likely march toward the authorized 400 million shares. Plenty of room for speculation -- so much potential and so many unknowns.